The Cardio-protective Effect of Cardiomyopeptidin on Myocardial Injury in ICU Patients With Non-organic Heart Disease: a Prospective, Single-blind, Randomized Controlled Pilot Study

NCT06117046 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

234

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Injury
ICU

Interventions

DRUG: Cardiopeptidin
DRUG: 50 ml of normal saline intravenous infusion

Sponsor

Nanfang Hospital, Southern Medical University